Considering our experience in this review, we focus on the instrumental morpho-functional approach for classifying the suitability of gene treatment in different forms of IRDs, starting from those with RPE65 gene mutation, who are presently suitable for gene therapy. The gene discussed is RPE65; the disease is respiratory distress syndrome in premature infants.